Jackson Laboratory

The Jackson Laboratory was founded in Bar Harbor, Maine in 1929 by former University of Maine and University of Michigan president C. C. Little under the name Roscoe B. Jackson Memorial Laboratory. The Jackson Laboratory is an independent, nonprofit biomedical research institution, dedicated to contributing to a future of better health care based on the unique genetic makeup of each individual. With more than 1,400 employees in Bar Harbor, Maine, and Sacramento, California, the Laboratory's mission is to discover the genetic basis for preventing, treating and curing human diseases, and to enable research and education for the global biomedical community. The institution is a National Cancer Institute-designated Cancer Center and has NIH centers of excellence in aging and systems genetics. The Laboratory is also the world's source for more than 5,000 strains of genetically defined mice, is home of the mouse genome database and is an international hub for scientific courses, conferences, training and education.

Website
http://www.jax.org/
Wikipedia
http://en.wikipedia.org/wiki/Jackson_Laboratory

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Medical research

Connecticut legislature approves historic endometriosis bill

Connecticut is poised to become a hub for endometriosis research and innovation following the unanimous passage of House Bill 6672, "An Act Concerning Endometriosis," which creates a first-of-its-kind endometriosis data and ...

Diseases, Conditions, Syndromes

The many manifestations of long COVID

Over the past three years, it has become clear that, for many people, the effects of SARS-CoV-2 infection persist long after an initial case of COVID-19 wanes.

Oncology & Cancer

How do gliomas evolve?

The Glioma Longitudinal Analysis (GLASS) Consortium characterized diffuse glioma cells both before and after therapy to characterize how they change and why this form of malignant brain cancer is so difficult to treat. The ...

Oncology & Cancer

New way to target advanced breast cancers

A cytokine signature found in certain kinds of breast cancer cells can not only serve as a diagnostic tool for HER2-negative cancers but also offer an effective treatment target.

page 1 from 4